Early detection of chemoresistance in vivo through the use of a radiolabeled antisense oligonucleotide

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3349-3356

  Touboul, Muriel ^a   Gauchez, Anne Sophie ^a,b   Moulinet D'Hardemare, Amaury Du ^a   Lunardi, Joël ^b   Deverre, Jean Robert ^c   Pernin, Claude ^a   Mathieu, Jean Paul ^a   Vuillez, Jean Philippe ^a   Fagret, Daniel ^a  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Institut National de la Recherche Agronomique   (France)

Author keywords

Antisense; Chemoresistance; Diagnosis; hmdr1; Radiolabeled oligonucleotide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; IODINE 125; MESSENGER RNA; PHOSPHORAMIDIC ACID DERIVATIVE;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL STRAIN K 562; CHEMICAL MODIFICATION; CODON; DIAGNOSTIC IMAGING; FEMALE; GENE; GENE EXPRESSION; GENE TARGETING; HMDR1 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SKELETAL MUSCLE; TRANSLATION INITIATION; TUMOR DIAGNOSIS; TUMOR RESISTANCE;

EID: 0036871631     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gauchez AS, du Moulinet d'Hardemare A, Lunardi J, Vuillez JP and Fagret D: Potential use of radiolabeled antisense oligonucleotides in oncology. Anticancer Research 19: 4989-4998, 1999.
2. Feinendegen LE: Biological damage from the Auger effect, possible benefits. Rad and Environm Biophys 12: 85-99, 1995.
3. O'Donoghue JA: Strategies for selective targeting of Auger electron emitters to tumor cells. J Nucl Med 37: 4 suppl, 3S-6S, 1996.
4. Bourhis J, Goldstein LJ, Riou G, Pastan I, Gottesman MM and Benard J: Expression of a human multidrug resistance gene in ovarian carcinomas. Cancer Res 49: 5062-5065, 1989.
5. Kohno K, Sato SI, Takano H, Matsuo KI and Kuwano M: The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Comm 165: 1415-1421, 1989.
6. Klasa RJ, Bally MB, Ng R, Goldie JH, Gascoyne RD and Wong FMP: Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide. Clin Canc Res 6: 2492-2500, 2000.
7. Carpentier AF, Xie J, Mokhtari K and Delattre JY: Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin Canc Res 6: 2469-2473, 2000.
8. Bradley G, Juranka PF and Ling V: Mechanism of multidrug resistance. Biochem Biophys Acta 948: 87-128, 1988.
9. Benard J, Da Silva J, de Blois MC, Boyer P, Duvillard P, Chiric E and Riou G: Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res 45: 4970-4979, 1995.
10. Benard J, Da Silva J, Teyssier JR and Riou G: Over-expression of MDR1 gene with no DNA amplification in a multiple-drug resistant human ovarian carcinoma cell line. Int J Cancer 43: 471-477, 1989.
11. Gauchez AS, Lunardi J, Pernin C, Marti-Battle D and Fagret D: Detection of chemoresistance profile of cell lines K562, KB, GLC4 and HL60 through characterisation of the hmdr1, mrp et lrp transcripts. In Vivo 15: 101-104, 2001.
12. Fontanel MC, Bazin H, Roger A, Teoule R: Synthesis and use of 4-hydroxyphenyl derivatized phosphoramidites an the selective radioiodination of oligonucleotides probes. J Labeled Compounds and Radiopharmaceuticals XXXIII, 717-72, 1993.
13. Deverre JR, Boutet V, Boquet D, Ezan E, Grassi J and Grognet JM: A competitive enzyme hybridization assay for plasma determination of phosphodiester and phosphorothioate antisense oligonucleotides. Nucl Acid Res 25,18: 3584-3589, 1997.
14. Lowry OH, Rosebrough NJ, Faar AL and Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275, 1951.
15. Lima WF, Monia BP, Ecker DJ and Freier SM: Implication, of RNA structure, on antisense oligonucleotide hybridization kinetics. Biochem 31: 12055-12061, 1992.
16. Dewanjee MK, Ghafouripour AK, Kapadvanjwala M, Dewanjee S, Serafini AX, Lopez DM and Sfakianakis GN: Non-invasive imaging of c-myc oncogene messenger RNA with indium-111 antisense probes in a mammary tumor-bearing mouse model. J Nucl Med 35: 1054-1063, 1994.
17. Cammilleri S, Perdereau B, Brixy F, Pierga JY, Benyahia B, Chypre C and Magdelenat H: Imaging and biodistribution of 1125 tyramine oligonucleotide in nude mice bearing human breast tumor. Preliminary report. Bull Cancer 83: 23-26, 1996a.
18. Cammilleri S, Sangrajrang S, Perdereau B, Brixy F, Calvo F, Bazin H and Magdelenat H: Biodistribution of iodine-125 tyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injection. Eur J of Nucl Med 23: 448-452, 1996b.
19. Capaccioli S, Di Pasquale G, Mini E, Mazzei T and Quattrone A: Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Com 2: 818-825, 1993.
20. Clarenc JP, Degols G, Leonetti JP, Milhaud PP and Lebleu B: Delivery of antisense oligonucleotides by poly (L-lysine) conjugation and liposome encapsulation. Anti Cancer Drug Design 8: 81-94, 1993.
21. Lemaitre M, Bayard B and Lebleu B: Specific antiviral activity of a poly (L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc Natl Acad Sci USA 84: 648-652, 1987.
22. Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen JS and Neckers LM: Characterization of oligonucleotide transport into living cells. Proc Natl Acad USA 86: 3474-3478, 1989.
23. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, DemeneiX B and Behr JP: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92: 7297-7301, 1995.
24. Feger J, Gil-Falgon S and Lamaze C: Cell receptors: Definition, mechanisms and regulation of receptor-mediated endocytosis. Cell Mol Biol 40: 1039-1061, 1994.
25. Tavitian B, Terrazzino S, Kuhnast B, Marzabal S, Stettler O, Dolle F, Deverre JR, Jobert A, Hinnen F, Bendriem B, Crouzel C and Di Giamberardino L: In vivo imaging of oligonucleotides with positron emission tomography. Nature Medicine 4: 467-4717 1998.
26. 125) chez la souris saine. Medecine Nucleaire Imagerie Fonctionnelle et Metabolique 19: 20-24, 1995.
27. Tavitian B: In vivo antisense imaging. Q J Nucl Med 44: 236-55, 2000.